A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Clinical trial NCT02367313 · COMPLETED
Trial details
- NCT number
- NCT02367313
- Sponsor
- Biota Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-12-01
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.